Results 91 to 100 of about 687 (125)

Publication Only

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Dimethyl fumarate for treating Papillon–Lefèvre syndrome

JAAD Case Reports, 2023
Abdullah Al-Omair, MD, Muteb Alharbi, MD, Asem Almesfer, MD   +2 more
doaj   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Dimethyl fumarate for psoriasis

Drug and Therapeutics Bulletin, 2017
Dimethyl fumarate (Skilarence - Almirall) was licensed by the European Medicines Agency in June 2017 for the treatment of moderate to severe plaque psoriasis in adults in need of systemic therapy.1 An unlicensed formulation of dimethyl fumarate has been used in the UK for the management of psoriasis for several years. Here, we consider the evidence for
openaire   +2 more sources

Dimethyl fumarate

Reactions Weekly, 2019
  +9 more sources

Dimethyl Fumarate

Reactions Weekly, 2022
Oonagh Molloy, Brian Kirby
  +4 more sources

Dimethyl fumarate

Reactions Weekly, 2016
  +7 more sources

Dimethyl fumarate

Reactions Weekly, 2018
  +8 more sources

Dimethyl fumarate

Reactions Weekly, 2021
  +5 more sources

Dimethyl Fumarate

Dermatitis, 2011
Magnus, Bruze, Erik, Zimerson
openaire   +2 more sources

Lorcaserin, dimethyl fumarate, and bedaquiline fumarate

Journal of the American Pharmacists Association, 2013
Daniel A, Hussar, Georgiy, Polyak
openaire   +2 more sources